Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements.
Kato D, Takashima H, Waseda K, Kurita A, Kuroda Y, Kosaka T, Kuhara Y, Ando H, Maeda K, Kumagai S, Sakurai S, Suzuki A, Toda Y, Watanabe A, Sato S, Fujimoto M, Mizuno T, Amano T. Kato D, et al. Among authors: takashima h. Heart Vessels. 2015 Jul;30(4):477-83. doi: 10.1007/s00380-014-0508-5. Epub 2014 Apr 19. Heart Vessels. 2015. PMID: 24748047
Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.
Takashima H, Ozaki Y, Morimoto T, Kimura T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Daida H, Mizuno T, Asai K, Kuroda Y, Kosaka T, Kuhara Y, Kurita A, Maeda K, Amano T, Matsuzaki M; JAPAN-ACS Investigators. Takashima H, et al. Circ J. 2012;76(12):2840-7. doi: 10.1253/circj.cj-11-1495. Epub 2012 Sep 7. Circ J. 2012. PMID: 22972364 Free article. Clinical Trial.
Prognostic impact of concurrence of metabolic syndrome and chronic kidney disease in patients undergoing coronary intervention: Involvement of coronary plaque composition.
Kunimura A, Amano T, Uetani T, Harada K, Yoshida T, Suzuki A, Shimbo Y, Kitagawa K, Harada K, Kato B, Kato M, Takashima H, Ando H, Matsubara T, Ishii H, Murohara T. Kunimura A, et al. Among authors: takashima h. J Cardiol. 2013 Mar;61(3):189-95. doi: 10.1016/j.jjcc.2012.10.003. Epub 2012 Nov 22. J Cardiol. 2013. PMID: 23182943 Free article.
Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
Ando H, Amano T, Takashima H, Harada K, Kitagawa K, Suzuki A, Kunimura A, Shimbo Y, Harada K, Yoshida T, Kato B, Uetani T, Kato M, Matsubara T, Kumagai S, Yoshikawa D, Isobe S, Ishii H, Murohara T. Ando H, et al. Among authors: takashima h. Eur Heart J Cardiovasc Imaging. 2013 Oct;14(10):996-1001. doi: 10.1093/ehjci/jet003. Epub 2013 Jan 22. Eur Heart J Cardiovasc Imaging. 2013. PMID: 23341147
Prognostic impact of lipid contents on the target lesion in patients with drug eluting stent implantation.
Kumagai S, Takashima H, Waseda K, Ando H, Suzuki A, Uetani T, Harada K, Yoshida T, Kunimura A, Shimbo Y, Kitagawa K, Harada K, Ishii H, Yoshikawa D, Matsubara T, Murohara T, Amano T. Kumagai S, et al. Among authors: takashima h. Heart Vessels. 2014 Nov;29(6):761-8. doi: 10.1007/s00380-013-0430-2. Epub 2013 Oct 20. Heart Vessels. 2014. PMID: 24142068
889 results